Comparison of zero- and second-order derivative spectrophotometric and HPLC methods for the determination of gemcitabine in human plasma

Farmaco

Volumn 59, Issue 5, 2004, Pages 425-429

  Yilmaz, Bilal ^a   Kadioǧlu, Yücel ^a  

^a ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Derivative spectrophotometry; Gemcitabine; High performance liquid chromatography

Indexed keywords

DEOXYCYTIDINE; GEMCITABINE;

ACCURACY; ARTICLE; CALIBRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIODE; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; PLASMA; QUANTITATIVE ANALYSIS; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEOXYCYTIDINE; HUMANS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 2142668218     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2004.01.013     Document Type: Article

References (13)

1. Hertel L.W., Kroin J.S., Misner J.W., Justin J.M. Synthesis of 2- deoxy-2, 2- difluoro-ribose and 2-deoxy-2, 2-difluoro-ribofuronosyl nucleosides. Journal of Organic Chemistry. 53:1998;2406-2409
2. Van Moorsel C.J.A., Peters G.J., Pinedo H.M. Gemcitabine; future prospects of single-agents and combination studies. The Oncologist. 2:1997;127-134
3. Freeman K.B., Anliker S., Hamilton M., Osborne D., Dhahir P.H., Nelson R., Allerheiligen S.R.B. Validated assays for the determination of gemcitabine in plasma and urine using high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography B. 665:1995;171-181
4. Abbruzzese J.L., Grunewald R., Weeks E.A., Gravel D., Adams T., Nowak B., Mineishi S., Tarassoff P., Satterlee W., Raber M.N., Plunkett W. A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. Journal of Clinical Oncology. 9:1991;491
5. 19F Nuclear Magnetic Resonance Spectroscopy. Analytical Biochemistry. 214:1993;25-30
6. Cozzi P.J., Bajorin D.F., Tong W., Nguyen H., Scott J., Heston W.D.W., Dalbagni G. Toxicology pharmacokinetics of intravesical Gemcitabine: A preclinical study in dogs. Clinical Cancer Research. 5:1999;2629-2637
7. Van Moorsel C.J.A., Pinedo H.M., Smid K., Comijn E.M., Voorn D.A., Veerman G., Lakerveld B., Van der Vijgh W.J.F., Giaccone G., Postmus P.E., Peters G.J. Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin in mice bearing Lewis lung murine non-small cell lung tumours. European Journal of Cancer. 36:2000;2420-2429
8. Grunewald R., Kantarjian H., Du M., Faucher K., Tarassoff P., Plunkett W. Gemcitabine in leukemia: a phase I clinical, plasma and cellular pharmacology study. Journal of Clinical Oncology. 10:1992;406
9. Blackstock A.W., Lightfoot H., Case L.D., Tepper J.E., Mukherji S.K., Mitchell B.S., Swarts S.G., Hess S.M. Tumor Uptake and Elimination of 2', 2'-Difluoro-2'-deoxycytidine (Gemcitabine) after Deoxycytidine Kinase Gene Transfer: Correlation with in Vivo Tumor Response. Clinical Cancer Research. 7:2001;3263-3268
10. Kerr J.Z., Berg S.L., Dauser R., Nuchtern J., Egorin M.J., McGuffey L., Aleksic A., Blaney S. Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primates. Cancer Chemotherapy and Pharmacology. 47:2001;411-414
11. Yilmaz B., Kadioglu Y.Y., Aksoy Y. Simultaneous analysis of gemcitabine and its metabolite in human plasma by high-performance liquid chromatography. Journal of Chromatography B. 791:2003;103-109
12. Keith B., Xu Y., Grem J.L. Measurement of the anti-cancer agent gemcitabine in human plasma by high-performance liquid chromatography. Journal of Chromatography B. 785:2003;65-72
13. Hubert P., Chiap P., Moors M., Bourguignon B., Massart D.L., Crommen J. Knowledge-based system for the automated solid-phase extraction of basic drugs from plasma coupled with their liquid chromatographic determination: Application to the biodetermination of β-receptor blocking agents. Journal of Chromatography A. 665:1994;87-99